» Articles » PMID: 11129214

Drug and Toxin-induced Bile Duct Disorders

Overview
Specialty Gastroenterology
Date 2000 Dec 29
PMID 11129214
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Various drugs of toxins have been implicated in the development of a particular form of liver damage predominantly involving the bile ducts. Such liver toxicity is often associated with a clinical picture of prolonged cholestasis and may even evolve in rare instances, into the full picture of the vanishing bile duct syndrome, eventually complicated with biliary cirrhosis. Drug and toxins potentially responsible for bile duct injury are reviewed as well as the characteristics of its clinical presentation. The pathophysiologic aspects of the syndrome are also reviewed including recent data, which are strongly in favor of the role of a genetic predisposition.

Citing Articles

Acquired ductopenia: an insight into imaging findings.

Khot R, Shelman N, Ludwig D, Nair R, Anderson M, Venkatesh S Abdom Radiol (NY). 2024; 50(1):152-168.

PMID: 38954003 PMC: 11711635. DOI: 10.1007/s00261-024-04462-x.


Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis.

Wang J, Wang S, Wu C, Deng Z Infection. 2023; 52(3):891-899.

PMID: 37996645 DOI: 10.1007/s15010-023-02132-6.


Cholangiokines: undervalued modulators in the hepatic microenvironment.

Cai X, Tacke F, Guillot A, Liu H Front Immunol. 2023; 14:1192840.

PMID: 37261338 PMC: 10229055. DOI: 10.3389/fimmu.2023.1192840.


Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim/sulfamethoxazole: a case report.

van Asperdt J, De Moor R BMC Pediatr. 2021; 21(1):345.

PMID: 34399711 PMC: 8365906. DOI: 10.1186/s12887-021-02820-y.


Paraneoplastic Intrahepatic Cholestasis in Supradiaphragmatic Classical Hodgkin Lymphoma Successfully Treated With Brentuximab Vedotin: A Case Report and Review of the Literature.

Papakonstantinou I, Kosmidou M, Papathanasiou K, Koumpis E, Kapsali E, Milionis H In Vivo. 2021; 35(4):1951-1957.

PMID: 34182468 PMC: 8286474. DOI: 10.21873/invivo.12462.